Liquid Biopsies – Multimedia

This article explores how cell-to-cell communication can be targeted for novel treatment methods.

Liquid biopsies are a minimally invasive alternative that can detect the presence of circulating tumor cells (CTCs) and circulating tumor DNA (ctDNA) as tumor biomarkers.

This whitepaper demonstrates how common methylation detection methods can be combined with Droplet Digital PCR (ddPCR) to enhance the cfDNA analysis for clinical and research applications.

This poster describes an optimized target enrichment protocol designed to enhance the capture and conversion of fragmented cfDNA for reliable NGS.

Automated cell imaging and picking systems can unlock the full potential of CTCs, with rapid, automated and highly accurate methods for isolation, enrichment and identification.

This poster highlights how this technology can provide accurate detection of genetic variants and variant-associated methylation in colorectal cancer samples.

In this episode we speak with Tom Charlesworth and discuss how the 6-base genome can improve the understanding tumour biology from liquid biopsy.

Learn what truly matters in cfDNA quality analysis. The Agilent Cell-free ScreenTape assay for the Agilent TapeStation systems uses the %cfDNA score to characterize HMW contamination and provides the actual cfDNA concentration.

This application note presents the latest electrophoretic solutions for a more rapid assessment of cfDNA samples and optimal biomarker discovery.

Isolating single cells is crucial in various research fields such as rare-cell analysis, biologics discovery and stem cell research. However, the process of identifying and isolating productive single cells remains a significant challenge, partly due to resource-intensive and often ineffective techniques like limiting dilution.